House of Commons Science and Technology Committee: emerging diseases and learnings from COVID-19 inquiry

The House of Commons Science and Technology Committee has launched an inquiry on emerging diseases and lessons learned from COVID-19 to determine what went well during the pandemic and to identify areas of weakness to ensure the UK is well placed tackle future public health emergencies. We consulted with members that were directly involved in the national response to the pandemic and submitted a cohesive response that reflects the opinions and experiences of the Microbiology Society community. Our response focuses on pandemic preparedness, testing capacity and approach, and emerging diseases.

We note that our response reflects the views expressed by eight individuals who responded to our call for input.